Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer

NCT00384878 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: Cetuximab, Cisplatin,5-Fluorouracil,Leucovorin

Sponsor

Far Eastern Memorial Hospital